Cargando…

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has raised concerns in patients with inflammatory bowel disease (IBD), not only due to consequences of coronavirus disease 2019 itself but also as a possible cause of IBD relapse. The main objective of this study was to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papa, Alfredo, Scaldaferri, Franco, Covino, Marcello, Tursi, Antonio, Furfaro, Federica, Mocci, Giammarco, Lopetuso, Loris Riccardo, Maconi, Giovanni, Bibbò, Stefano, Fiorani, Marcello, Laterza, Lucrezia, Mignini, Irene, Napolitano, Daniele, Parisio, Laura, Pizzoferrato, Marco, Privitera, Giuseppe, Pugliese, Daniela, Schepis, Tommaso, Schiavoni, Elisa, Settanni, Carlo Romano, Vetrone, Lorenzo Maria, Armuzzi, Alessandro, Danese, Silvio, Gasbarrini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029341/ https://www.ncbi.nlm.nih.gov/pubmed/35453593 http://dx.doi.org/10.3390/biomedicines10040843

Ejemplares similares

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
por: Covino, Marcello, et al.
Publicado: (2021)

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab
por: Pugliese, Daniela, et al.
Publicado: (2022)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach
por: Tursi, Antonio, et al.
Publicado: (2022)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2018)

Microbiota Composition in Diverticular Disease: Implications for Therapy
por: Tursi, Antonio, et al.
Publicado: (2022)

Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase
por: Papa, Alfredo, et al.
Publicado: (2020)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
por: Del Vecchio, Livio Enrico, et al.
Publicado: (2022)

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center
por: Pizzoferrato, Marco, et al.
Publicado: (2019)

Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
por: Papa, Alfredo, et al.
Publicado: (2023)

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
por: Gaetani, Eleonora, et al.
Publicado: (2018)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy
por: De Siena, Martina, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
por: Mocci, Giammarco, et al.
Publicado: (2022)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
por: Lopetuso, Loris R, et al.
Publicado: (2012)

Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
por: Caruso, C., et al.
Publicado: (2023)

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
por: Rinninella, Emanuele, et al.
Publicado: (2020)

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
por: Rinninella, Emanuele, et al.
Publicado: (2019)

Role of gut microbiome on immunotherapy efficacy in melanoma
por: Bibbò, Stefano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6a65n2ck9je608j4q01hf4acn